Investigation of degradation products of secondary metabolites of Bupropion molecule by DFT methods

dc.contributor.authorKurumoglu, S.
dc.contributor.authorGurkan, Y.Y.
dc.date.accessioned2024-10-29T17:43:36Z
dc.date.available2024-10-29T17:43:36Z
dc.date.issued2023
dc.departmentTekirdağ Namık Kemal Üniversitesi
dc.description.abstractEvery substance (food, drug, etc.) taken into the body is excreted from the body by enzymatic mechanisms and given to the natural environment it pollutes the nature. Data from the Ministry of Health show that the amount of antidepressant use has increased by about 70 percent in the 11 years until 2020. According to the latest health statistics of the Ministry for 2020, while 29 antidepressant drugs per 1000 people per day were registered in 2009, this rate increased to 49 in 2020. In addition to its use as an antidepressant, Bupropion is also used in the treatment of smoking cessation, methamphetamine and cocaine addiction, behavioral addictions such as pathological gambling, and attention deficit hyperactivity disorder. Our aim is to optimize with DFT method the 3 secondary metabolites of Bupropion, which are formed because of enzymatic reactions after the drug is taken into the body. It is to theoretically explain the degradation pathways the secondary metabolites given to the natural environment with urine may be exposed to. © 2023 Bulgarian Academy of Sciences, Union of Chemists in Bulgaria.
dc.identifier.doi10.34049/bcc.55.3.NCNTC12
dc.identifier.endpage307
dc.identifier.issn0861-9808
dc.identifier.issue3en_US
dc.identifier.scopus2-s2.0-85174159971
dc.identifier.scopusqualityQ4
dc.identifier.startpage299
dc.identifier.urihttps://doi.org/10.34049/bcc.55.3.NCNTC12
dc.identifier.urihttps://hdl.handle.net/20.500.11776/12511
dc.identifier.volume55
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherBulgarska Akademiya na Naukite
dc.relation.ispartofBulgarian Chemical Communications
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAntidepressant
dc.subjectBupropion
dc.subjectDFT
dc.subjectGaussian 09
dc.titleInvestigation of degradation products of secondary metabolites of Bupropion molecule by DFT methods
dc.typeArticle

Dosyalar